Required for operating procedures within a medical treatment facility
Ended Awarded Last action
- Contract number
- HT009026FG0130023
- Awardee
-
Abbott Laboratories Inc. UEI NH3LDK8CFAK7 Part of Abbott Laboratories Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $14,698
Award facts
- Contract value 100% obligated
- $14,697.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 5680 Miscellaneous Construction Materials
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- North Chicago, IL 60064, USA
Award details come from SAM.gov/FPDS.
About this award
Abbott Laboratories Inc., through its Abbott Diagnostics Division, was awarded a Blanket Purchase Agreement (BPA) call valued at $14,697.82 on January 16, 2026, by the Defense Health Agency to provide required operating procedures and supplies for a medical treatment facility located in North Chicago, Illinois. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 30, 2026. No small business set-aside designation was applied to this award, indicating Abbott competed in the full and open marketplace. This call order falls under a parent BPA vehicle and represents Abbott's ongoing role as a primary supplier of diagnostic equipment, reagents, and clinical laboratory services to the Defense Health Agency's healthcare operations.
Abbott Diagnostics Division maintains an extensive federal contract portfolio with the Defense Health Agency and other Department of Defense healthcare entities, delivering sophisticated laboratory analyzers, diagnostic reagents, and clinical testing supplies. The company holds multiple master indefinite delivery and BPA vehicles with various federal healthcare agencies, including several with the Department of Veterans Affairs across multiple Integrated Service Networks, collectively representing over $200 million in cumulative obligations. Abbott's established presence as a defense contractor reflects the critical role its diagnostic and medical device solutions play in supporting military healthcare operations and federal medical treatment facility requirements.
Quick answers
Who was awarded contract HT009026FG0130023?
HT009026FG0130023 was awarded to Abbott Laboratories Inc. by Defense Health Agency (Department of Defense) on January 16, 2026.
How much is contract HT009026FG0130023 worth?
The government has obligated $14,698 on HT009026FG0130023.
Is contract HT009026FG0130023 an order under another contract?
Yes. HT009026FG0130023 is a BPA call under FA301624A0044, a blanket purchase agreement.
Was contract HT009026FG0130023 competed?
The extent of competition for HT009026FG0130023 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award